Becton, Dickinson & Co. (BDX)
213.55
+4.36
(+2.08%)
USD |
NYSE |
Nov 05, 16:00
213.51
-0.04
(-0.02%)
Pre-Market: 20:00
Becton, Dickinson SG&A Expense (TTM) : 3.867B for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.867B |
| June 30, 2026 | 5.233B |
| March 31, 2026 | 5.292B |
| December 31, 2025 | 5.352B |
| September 30, 2025 | 5.277B |
| June 30, 2025 | 5.167B |
| March 31, 2025 | 5.043B |
| December 31, 2024 | 4.963B |
| September 30, 2024 | 4.858B |
| June 30, 2024 | 4.739B |
| March 31, 2024 | 4.733B |
| December 31, 2023 | 4.745B |
| September 30, 2023 | 4.719B |
| June 30, 2023 | 4.764B |
| March 31, 2023 | 4.723B |
| December 31, 2022 | 4.75B |
| September 30, 2022 | 4.748B |
| June 30, 2022 | 4.851B |
| March 31, 2022 | 4.902B |
| December 31, 2021 | 4.818B |
| September 30, 2021 | 4.782B |
| June 30, 2021 | 4.697B |
| March 31, 2021 | 4.477B |
| December 31, 2020 | 4.354B |
| September 30, 2020 | 4.326B |
| Date | Value |
|---|---|
| June 30, 2020 | 4.22B |
| March 31, 2020 | 4.316B |
| December 31, 2019 | 4.38B |
| September 30, 2019 | 4.332B |
| June 30, 2019 | 4.339B |
| March 31, 2019 | 4.349B |
| December 31, 2018 | 4.316B |
| September 30, 2018 | 4.017B |
| June 30, 2018 | 3.69B |
| March 31, 2018 | 3.323B |
| December 31, 2017 | 2.991B |
| September 30, 2017 | 2.926B |
| June 30, 2017 | 2.948B |
| March 31, 2017 | 2.957B |
| December 31, 2016 | 2.965B |
| September 30, 2016 | 3.004B |
| June 30, 2016 | 2.964B |
| March 31, 2016 | 3.00B |
| December 31, 2015 | 2.779B |
| September 30, 2015 | 2.575B |
| June 30, 2015 | 2.38B |
| March 31, 2015 | 2.144B |
| December 31, 2014 | 2.158B |
| September 30, 2014 | 2.145B |
| June 30, 2014 | 2.461B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 15.16B |
| Boston Scientific Corp. | 7.101B |
| Stryker Corp. | 9.05B |
| Globus Medical, Inc. | 1.217B |
| Baxter International, Inc. | 2.954B |